15 January 2019 1 Min Read
Edward Lifesciences pays Boston Scientific $180m to end patent row
The settlement is seen as positive for the industry as a whole
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In